Continuous vs. fixed duration therapy for multiple myeloma?

Continuous vs. fixed duration therapy for multiple myeloma?

User Photo
VJHemOnc

1 year
64 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, discusses continuous and fixed duration therapy.
Up Next Autoplay